[Research progress in targeting DNA G-quadruplexes using natural products].

Q3 Pharmacology, Toxicology and Pharmaceutics Zhongguo Zhongyao Zazhi Pub Date : 2024-07-01 DOI:10.19540/j.cnki.cjcmm.20240325.601
Zhi-Yuan Chen, Rong-Shuang Cheng, Wubulikasimu Ayixia, Yu-Shuang Liu, Kai-Bo Wang
{"title":"[Research progress in targeting DNA G-quadruplexes using natural products].","authors":"Zhi-Yuan Chen, Rong-Shuang Cheng, Wubulikasimu Ayixia, Yu-Shuang Liu, Kai-Bo Wang","doi":"10.19540/j.cnki.cjcmm.20240325.601","DOIUrl":null,"url":null,"abstract":"<p><p>DNA G-quadruplex(G4) is a guanine-rich single-stranded DNA sequence that spontaneously folds into a spherical four-stranded DNA secondary structure in oncogene promoter sequences and telomeres. G4s are highly associated with the occurrence and development of cancer and have emerged as promising anticancer targets. Natural products have long been important sources of anticancer drug development. In recent years, significant progress has been made in the discovery of natural drugs targeting DNA G4s, with many DNA G4s have been confirmed as promising targets of natural products, including MYC-G4, KRAS-G4, PDGFR-β-G4, BCL-2-G4, VEGF-G4, and telomeric G4. This review summarizes the research progress in discovering natural small molecules that target DNA G4s and their binding mechanisms. It also discusses the opportunities of and challenges in developing drugs targeting DNA G4s. This review will serve as a valuable reference for the research on natural products, particularly in the development of novel antitumor medications.</p>","PeriodicalId":52437,"journal":{"name":"Zhongguo Zhongyao Zazhi","volume":"49 13","pages":"3421-3431"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhongguo Zhongyao Zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19540/j.cnki.cjcmm.20240325.601","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

DNA G-quadruplex(G4) is a guanine-rich single-stranded DNA sequence that spontaneously folds into a spherical four-stranded DNA secondary structure in oncogene promoter sequences and telomeres. G4s are highly associated with the occurrence and development of cancer and have emerged as promising anticancer targets. Natural products have long been important sources of anticancer drug development. In recent years, significant progress has been made in the discovery of natural drugs targeting DNA G4s, with many DNA G4s have been confirmed as promising targets of natural products, including MYC-G4, KRAS-G4, PDGFR-β-G4, BCL-2-G4, VEGF-G4, and telomeric G4. This review summarizes the research progress in discovering natural small molecules that target DNA G4s and their binding mechanisms. It also discusses the opportunities of and challenges in developing drugs targeting DNA G4s. This review will serve as a valuable reference for the research on natural products, particularly in the development of novel antitumor medications.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[利用天然产品靶向 DNA G-四联体的研究进展]。
DNA G-四叠体(G4)是一种富含鸟嘌呤的单链 DNA 序列,可在癌基因启动子序列和端粒中自发折叠成球形的四链 DNA 二级结构。G4 与癌症的发生和发展高度相关,已成为有前景的抗癌靶点。长期以来,天然产物一直是抗癌药物开发的重要来源。近年来,以DNA G4为靶点的天然药物的发现取得了重大进展,许多DNA G4已被证实为天然产物的有望靶点,包括MYC-G4、KRAS-G4、PDGFR-β-G4、BCL-2-G4、VEGF-G4和端粒G4。本综述总结了发现靶向 DNA G4 的天然小分子及其结合机制的研究进展。它还讨论了开发 DNA G4 靶向药物的机遇和挑战。这篇综述将为天然产物研究,尤其是新型抗肿瘤药物的开发提供有价值的参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Zhongguo Zhongyao Zazhi
Zhongguo Zhongyao Zazhi Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.50
自引率
0.00%
发文量
581
期刊介绍:
期刊最新文献
[Effects of different light qualities on field-grown Epimedium pubescens]. [Construction and evaluation of an animal model of Alzheimer's disease with spleen-kidney deficiency and stagnant phlegm syndrome based on formula test]. [Effects and mechanisms of Renshen Guben Oral Liquid combined with Jingfang Granules on ovarian aging in perimenopausal mice]. [Concentration and pharmacokinetics of dihydroartemisinin in Beagle dog plasma determined by UPLC-MS/MS]. [Evidence mapping analysis of clinical research on TCM for diabetic kidney disease in recent six years].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1